Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06137040 · ClinicalTrials.gov registry record · Early Phase 1
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
A Early Phase 1 study of Asthma in Children and Asthma Attack, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06137040: Recruiting Early Phase 1 study of Asthma in Children and Asthma Attack, sponsored by University of Oklahoma.
NCT06137040 is a Early Phase 1 study of Asthma in Children and Asthma Attack that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 100 participants, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06137040, a Early Phase 1 study of Asthma in Children and Asthma Attack, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
Primary Outcome
Evaluating whether timely administration of IV magnesium sulfate in moderate asthma exacerbations can reduce length of stay in the ED, general hospital bed or PICU. The data will also be analyzed to determine if more patients in the experimental group were able to be discharged from the emergency department compared to the control group.
Conditions Studied
Interventions
- DRUG Magnesium Sulfate within the first hour
- OTHER No Magnesium sulfate within the first hour
Study Locations (1)
Oklahoma
- Oklahoma Children's Hospital - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-30 |
| Est. Completion | 2025-05-31 |
| Phase | Early Phase 1 |
What NCT06137040 shows while recruiting
NCT06137040 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (51% lower).
The record links to 2 conditions, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Magnesium Sulfate within the first hour is the first listed.
NCT06137040 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06137040 about?
NCT06137040 is a clinical study titled "Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation". This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU...
What is the current status of trial NCT06137040?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2023-11-30. Estimated completion is 2025-05-31.
What conditions does trial NCT06137040 study?
This clinical trial studies the following conditions: Asthma in Children, Asthma Attack.
What interventions are being tested in trial NCT06137040?
The interventions under investigation include: Magnesium Sulfate within the first hour (DRUG), No Magnesium sulfate within the first hour (OTHER).
Who is sponsoring clinical trial NCT06137040?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06137040 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06137040's enrollment target sits among peer trials
100 22nd of 44 higher than 23 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Wearable Electronic Breath Sound Sensing Device
RECRUITING
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI